So if you’re looking for the left-wing Joe Rogan, you're going to get a high-profile liberal white dude who's woke, smart, and kind of emo, in a self-assured sort of way.

Former president Joe Biden recently saw a doctor for symptoms, and on Friday was diagnosed with prostate cancer. On Sunday his office announced the cancer has “metastasized to the bone.” ...

AmerisourceBergen Corp, drug wholesaler, forecasts little change in sales and earnings for fiscal 2005 and says it might repurchase as much as $500 million in stock to increase per-share profit (S) ...

Marketing AmerisourceBergen is no more as it drops its 2-decade-old merger name to become Cencora By Ben Adams Aug 30, 2023 8:55am AmerisourceBergen branding Marketing ...

AmerisourceBergen officially has a new name: Cencora. The healthcare giant announced that it completed its name and stock ticker change Wednesday morning. The company said it has started trading under ...

AmerisourceBergen's Steven Collis with 5025 Plano Parkway (AmerisourceBergen, Google Maps, Getty) Jul 10, 2023, 5:30 PM By Erick Pirayesh Save article SHARE THIS ARTICLE FONT SIZE A A A ...

AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider tha ...

AmerisourceBergen released its platform focused on cell and gene therapies to speed the exchange of real-time data with the goal of aiding development and ultimately getting novel treatments to ...

AmerisourceBergen, TPG to acquire specialty practice network OneOncology in $2.1B deal By Heather Landi Apr 25, 2023 2:47pm AmerisourceBergen TPG OneOncology cancer care ...

AmerisourceBergen Corp. launched what it is calling a "Cell and Gene Therapy Integration Hub" to streamline the "path-to-care process" for such advanced medicines.

AmerisourceBergen in September struck a $1.3 billion deal to acquire Germany's PharmaLex, which provides biopharma companies services like clinical development consulting and market authorization.

With this deal, TPG will acquire a majority stake in OneOncology and AmerisourceBergen will take a minority stake in the company. The transaction puts OneOncology at a valuation of $2.1 billion.